Tuesday, July 15, 2025
spot_img

South Africa set to participate in two more vaccine trials

Date:

Share post:

spot_imgspot_img

Johannesburg: South Africa is all set to participate in two more COVID-19 vaccine trials by leading pharmaceutical companies starting next month.

Dr Glenda Gray, president and CEO of the South African Medical Research Council, said in an interview with the public interest health website Spotlight on Tuesday that a Johnson & Johnson product called Ad26.COV2-S and a Novavax product called NVX-CoV2373 will be trialled in the country.

The first COVID-19 vaccine trial on the African continent was the Ox1Cov-19 Vaccine VIDA trial, a collaboration with Oxford University, which was started in June in South Africa.

It is led by Professor in Vaccinology at Wits University Shabir Madhi.

Madhi, who is also the lead investigator for the Novavax trial in South Africa, told Spotlight that the Novavax trial to be conducted in South Africa will be a Phase IIb trial, which would measure efficacy, but not to the extent required for registration, for which a Phase III trial is typically needed. (Pti)

spot_imgspot_img

Related articles

Jadeja’s heroics in vain as India fall short at Lord’s

London, July 14: In a pulsating finish to the third Test at Lord’s, England held their nerve to...

Reprimand for Siraj for send-off to Ben Duckett in Lord’s Test

London, July 14: Indian fast bowler Mohammed Siraj has been officially reprimanded for an aggressive send-off directed at...

Odisha college principal arrested after student sets herself on fire

College student’s condition critical, but stable CONDITION CRITICAL BHUBANESWAR, July 14: The principal of a college in Odisha’s Balasore district...

Sinner claims maiden C’ship with win over Alcaraz

London, July 14: So much for theories: the idea that Jannik Sinner would be forever haunted by missing...